09:33 AM EDT, 06/27/2024 (MT Newswires) -- AbbVie ( ABBV ) said Thursday it has acquired privately held biotechnology company Celsius Therapeutics for $250 million in cash, subject to certain customary adjustments.
Price: 170.76, Change: -0.39, Percent Change: -0.23